Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia-Reference-Cited by-同舟云学术

Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia

Published:2016 Issue:23 Volume:6 Page:18980-18989
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Ayaz Ahmed Khan Behlol¹²³⁴⁵,Mahapatra Santanu Kar⁶⁷²³⁸,Charan Raja Mamilla R.⁶⁷²³⁸,Subramaniam Shankar¹²³⁴⁵,Sengan Megarajan¹²³⁴⁵,Rajendran Narendran¹²³⁴⁵,Das Sandeep Kumar⁹¹⁰¹¹¹²⁵,Haldar Kuntal¹³¹⁴¹⁵⁵,Roy Somenath⁹¹⁰¹¹¹²⁵,Sivasubramanian Aravind¹²³⁴⁵^ORCID,Anbazhagan Veerappan¹²³⁴⁵

Affiliation:

1. Department of Chemistry

2. School of Chemical and Biotechnology

3. SASTRA University

4. Thanjavur – 613 401

5. India

6. Medicinal Chemistry and Immunology Laboratory

7. Department of Biotechnology

8. Thanjavur-613 401

9. Immunology and Microbiology Laboratory

10. Department of Human Physiology with Community Health

11. Vidyasagar University